Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients:: A 6-year survey

被引:257
作者
Cornillet, A.
Camus, C.
Nimubona, S.
Gandemer, V.
Tattevin, P.
Belleguic, C.
Chevrier, S.
Meunier, C.
Lebert, C.
Aupee, M.
Caulet-Maugendre, S.
Faucheux, M.
Lelong, B.
Leray, E.
Guiguen, C.
Gangneux, J. -P.
机构
[1] Hop Pontchaillou, Lab Parasitol Mycol, F-35033 Rennes 9, France
[2] Aspergillosis Study Grp Rennes Teaching Hosp, Rennes, France
关键词
D O I
10.1086/505870
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Invasive aspergillosis is an opportunistic infection that occurs mainly among patients with prolonged neutropenia. Few data are available on invasive aspergillosis in nonneutropenic patients. Methods. The aim of this survey was to compare neutropenic and nonneutropenic patients who had received a diagnosis of invasive aspergillosis at our institution during a 6-year period. Results. Among the 88 cases of invasive aspergillosis analyzed here, 12 were histologically proven, 52 were probable, and 24 were possible. Forty-seven percent of cases were diagnosed in the intensive care unit, and 40% were diagnosed in hematology units. Neutropenia was a risk factor for 52 patients (59%), most of whom had hematological or solid malignancies. Among the 36 nonneutropenic patients (41%), the main underlying conditions were steroid-treated chronic obstructive pulmonary disease, asthma, rheumatoid arthritis, giant-cell arteritis, and microvascular disorders; 10 patients were recipients of solid-organ transplants, and 1 patient was seropositive for human immunodeficiency virus. The distribution of proven and probable invasive aspergillosis was similar for neutropenic and nonneutropenic patients. The mortality rate was 71.5% overall and was significantly higher among nonneutropenic patients than among neutropenic patients (89% vs. 60%;). Compared with neutropenic P < .05 patients, nonneutropenic patients were significantly less likely to have symptoms of invasive aspergillosis and more likely to have frequent intercurrent pneumonia due to another microorganism. The sensitivity of mycological examination of bronchoalveolar lavage fluid specimens was higher for nonneutropenic patients than for neutropenic patients (85% vs. 58%;), whereas the sensitivity of antigenemia was the same for the 2 populations (65% vs. 64%). Findings on thoracic computed tomographs were similar, except that segmental areas of consolidation occurred more frequently among neutropenic patients. Conclusion. This survey at a whole institution underlines the high number of cases of invasive aspergillosis among nonneutropenic patients, with an overall mortality rate that was significantly higher than that for neutropenic patients.
引用
收藏
页码:577 / 584
页数:8
相关论文
共 34 条
[1]   Invasive pulmonary aspergillosis:: Identification of risk factors [J].
Allam, MF ;
del Castillo, AS ;
Díaz-Molina, C ;
Navajas, RFC .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2002, 34 (11) :819-822
[2]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[3]   Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital [J].
Bouza, E ;
Guinea, J ;
Peláez, T ;
Pérez-Molina, J ;
Alcalá, L ;
Muñoz, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (05) :2075-2079
[4]  
Caillot D, 2001, Rev Prat, V51, P731
[5]   An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis [J].
Chow, L ;
Brown, NE ;
Kunimoto, D .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (09) :E106-E110
[6]   Fulminant invasive pulmonary aspergillosis in immunocompetent patients -: a two-case report [J].
Cornet, M ;
Mallat, H ;
Somme, D ;
Guérot, E ;
Kac, G ;
Mainardi, JL ;
Fornes, P ;
Gutmann, L ;
Lavarde, V .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (12) :1224-1227
[7]   Epidemiology of invasive aspergillosis in France:: a six-year multicentric survey in the Greater Paris area [J].
Cornet, M ;
Fleury, L ;
Maslo, C ;
Bernard, JF ;
Brücker, G .
JOURNAL OF HOSPITAL INFECTION, 2002, 51 (04) :288-296
[8]   Aspergillosis in "nonimmunocompromised" critically ill patients [J].
Denning, DW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (06) :580-581
[9]   Therapeutic outcome in invasive aspergillosis [J].
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) :608-615
[10]   Invasive aspergillosis [J].
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :781-803